Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_2
2
50%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Terminated(2)
Other(1)

Detailed Status

Terminated1
unknown1
Withdrawn1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (66.7%)
N/A1 (33.3%)

Trials by Status

terminated125%
unknown125%
withdrawn125%
completed125%

Recent Activity

0 active trials
Showing 4 of 4
withdrawn

Electrochemotherapy for Desmoid Tumors

NCT06660121
completedphase_2

Calcium Electroporation for Treatment of Cutaneous Metastases

NCT01941901
unknownphase_2

Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer

NCT03040180
terminatednot_applicable

Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer

NCT03225781

Clinical Trials (4)

Showing 4 of 4 trials
NCT06660121

Electrochemotherapy for Desmoid Tumors

Withdrawn
NCT01941901Phase 2

Calcium Electroporation for Treatment of Cutaneous Metastases

Completed
NCT03040180Phase 2

Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer

Unknown
NCT03225781Not Applicable

Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer

Terminated

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4